Literature DB >> 8741957

Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats.

A Besson1, A M Privat, A Eschalier, J Fialip.   

Abstract

The aim of this study was to investigate the possible involvement of the mu-opioid system on the learned-helplessness paradigm, an experimental model of depression, in rats. In this test, rats were first exposed to inescapable foot-shocks (IS); 48 h later, they were submitted to a daily shuttle-box session (30 trials) for 3 consecutive days. Avoidance responses, escape failures and animal activity during each intertrial interval were recorded. Twice daily injections of morphine (0.25-8 mg/kg per day, SC), a mu-opioid agonist, reduced the increased escape failures induced by IS, as did tricyclic antidepressants. Significantly higher intertrial activity was observed in rats treated with morphine (2-8 mg/kg per day) compared with their associated control groups. Naloxone (1 and 2 mg/kg, IP), a mu-opioid antagonist, injected 10 min before each shuttle-box session impaired escape behavior in non-stressed rats and worsened the escape deficit induced by IS. Morphine-induced improvement of escape behavior and increase in intertrial activity were clearly reversed by a low inactive dose of naloxone (0.5 mg/kg). These results suggest that mu-opioid receptor mediation is involved in the deleterious effects of uncontrollable stress.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741957     DOI: 10.1007/bf02246283

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

Review 1.  Animal behavioural studies in the evaluation of antidepressant drugs.

Authors:  M H Thiébot; P Martin; A J Puech
Journal:  Br J Psychiatry Suppl       Date:  1992-02

2.  Preexposure to foot-shock sensitizes the locomotor response to subsequent systemic morphine and intra-nucleus accumbens amphetamine.

Authors:  M Leyton; J Stewart
Journal:  Pharmacol Biochem Behav       Date:  1990-10       Impact factor: 3.533

Review 3.  Drugs of abuse: anatomy, pharmacology and function of reward pathways.

Authors:  G F Koob
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

Review 4.  Animal models of depression: an overview.

Authors:  P Willner
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

5.  Beta-endorphin responsiveness in depression.

Authors:  M A Morphy; G A Fava; N Sonino
Journal:  Arch Gen Psychiatry       Date:  1993-05

6.  Dissociation of antinociception and escape deficits induced by stress in mice.

Authors:  C Man; A Suissa; H Anisman
Journal:  J Comp Physiol Psychol       Date:  1980-12

7.  Morphine-induced hyperactivity in rats--a rebound effect?

Authors:  B Magnus-Ellenbroek; U Havemann-Reinecke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

8.  Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock.

Authors:  R C Drugan; S M Ryan; T R Minor; S F Maier
Journal:  Pharmacol Biochem Behav       Date:  1984-11       Impact factor: 3.533

9.  Reversal of helpless behavior in rats by putative 5-HT1A agonists.

Authors:  P Giral; P Martin; P Soubrié; P Simon
Journal:  Biol Psychiatry       Date:  1988-02-01       Impact factor: 13.382

10.  Exploration of mice in a black and white test box: validation as a model of anxiety.

Authors:  B Costall; B J Jones; M E Kelly; R J Naylor; D M Tomkins
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

View more
  8 in total

1.  Dynamics of neuronal, autonomic, and motor measures in animals performing an acquired habit.

Authors:  B V Zhuravlev; E P Murtazina
Journal:  Neurosci Behav Physiol       Date:  2003-10

Review 2.  Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.

Authors:  Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2011-02-24       Impact factor: 6.505

3.  Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.

Authors:  Andrew C Kruegel; Madalee M Gassaway; Abhijeet Kapoor; András Váradi; Susruta Majumdar; Marta Filizola; Jonathan A Javitch; Dalibor Sames
Journal:  J Am Chem Soc       Date:  2016-05-18       Impact factor: 15.419

4.  Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.

Authors:  Antonio Ortega-Alvaro; Ignacio Acebes; Gonzalo Saracíbar; Enrique Echevarría; Luis Casis; Juan Antonio Micó
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

Review 5.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

6.  The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist.

Authors:  M M Gassaway; M-L Rives; A C Kruegel; J A Javitch; D Sames
Journal:  Transl Psychiatry       Date:  2014-07-15       Impact factor: 6.222

Review 7.  Kappa Opioids, Salvinorin A and Major Depressive Disorder.

Authors:  George T Taylor; Francesca Manzella
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

8.  Transgenerational influence of parental morphine exposure on pain perception, anxiety-like behavior and passive avoidance memory among male and female offspring of Wistar rats.

Authors:  Hamid Ahmadian-Moghadam; Mitra-Sadat Sadat-Shirazi; Fereshteh Seifi; Saba Niknamfar; Ardeshir Akbarabadi; Heidar Toolee; Mohammad-Reza Zarrindast
Journal:  EXCLI J       Date:  2019-11-05       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.